4.7 Article

Activation of hypothalamic oxytocin neurons reduces binge-like alcohol drinking through signaling at central oxytocin receptors

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 46, Issue 11, Pages 1950-1957

Publisher

SPRINGERNATURE
DOI: 10.1038/s41386-021-01046-x

Keywords

-

Funding

  1. National Institute on Alcohol Abuse and Alcoholism [R01 AA026536, U01 AA014095, U24 AA020929, P50 AA0107061, F31 AA026483]
  2. VA Medical Research [I01BX000813]

Ask authors/readers for more resources

Both preclinical and clinical evidence suggest that exogenous administration of oxytocin may be a promising therapeutic strategy for reducing heavy alcohol drinking. This study demonstrates that targeted activation of hypothalamic oxytocin neurons can reduce alcohol consumption, indicating a role for oxytocin in the regulation of alcohol self-administration behavior. Furthermore, the ability of oxytocin to reduce alcohol drinking is mediated by signaling at oxytocin receptors in the brain.
Preclinical and clinical evidence suggests that exogenous administration of oxytocin (OT) may hold promise as a therapeutic strategy for reducing heavy alcohol drinking. However, it remains unknown whether these effects are mediated by stimulation of endogenous sources of OT and signaling at oxytocin receptors (OTR) in brain or in the periphery. To address this question, we employed a targeted chemogenetic approach to examine whether selective activation of OT-containing neurons in the paraventricular nucleus of the hypothalamus (PVN) alters alcohol consumption in a binge-like drinking (Drinking-in-the-Dark; DID) model. Adult male Oxt-IRES-Cre mice received bilateral infusion of a Cre-dependent virus containing an excitatory DREADD (AAV8-hSyn-DIO-hM3Dq-mCherry) or control virus (AAV8-hSyn-DIO-mCherry) into the PVN. Chemogenetic activation of PVNOT+ neurons following clozapine-N-oxide injection reduced binge-like alcohol drinking in a similar manner as systemic administration of the neuropeptide. Pretreatment with a brain-penetrant OTR antagonist (L-368,899) reversed this effect while systemic administration of a peripherally restricted OTR antagonist (Atosiban) did not alter reduced alcohol drinking following chemogenetic activation of PVNOT+ neurons. Altogether, these data are the first to demonstrate that targeted activation of hypothalamic (endogenous) OT reduces alcohol consumption, providing further evidence that this neuropeptide plays a role in regulation of alcohol self-administration behavior. Further, results indicate that the ability OT to reduce alcohol drinking is mediated by signaling at OTR in the brain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available